Omnicell Statistics
Total Valuation
Omnicell has a market cap or net worth of $2.07 billion. The enterprise value is $2.02 billion.
Important Dates
The last earnings date was Tuesday, April 28, 2026, before market open.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Omnicell has 45.48 million shares outstanding. The number of shares has decreased by -0.59% in one year.
| Current Share Class | 45.48M |
| Shares Outstanding | 45.48M |
| Shares Change (YoY) | -0.59% |
| Shares Change (QoQ) | +2.19% |
| Owned by Insiders (%) | 2.66% |
| Owned by Institutions (%) | 99.29% |
| Float | 41.95M |
Valuation Ratios
The trailing PE ratio is 103.42 and the forward PE ratio is 24.00. Omnicell's PEG ratio is 0.81.
| PE Ratio | 103.42 |
| Forward PE | 24.00 |
| PS Ratio | 1.69 |
| Forward PS | 1.64 |
| PB Ratio | 1.64 |
| P/TBV Ratio | 5.85 |
| P/FCF Ratio | 18.52 |
| P/OCF Ratio | 13.28 |
| PEG Ratio | 0.81 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 27.83, with an EV/FCF ratio of 18.08.
| EV / Earnings | 98.91 |
| EV / Sales | 1.65 |
| EV / EBITDA | 27.83 |
| EV / EBIT | 50.35 |
| EV / FCF | 18.08 |
Financial Position
The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.50 |
| Quick Ratio | 1.01 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 2.62 |
| Debt / FCF | 1.70 |
| Interest Coverage | 8.57 |
Financial Efficiency
Return on equity (ROE) is 1.63% and return on invested capital (ROIC) is 1.78%.
| Return on Equity (ROE) | 1.63% |
| Return on Assets (ROA) | 1.21% |
| Return on Invested Capital (ROIC) | 1.78% |
| Return on Capital Employed (ROCE) | 2.64% |
| Weighted Average Cost of Capital (WACC) | 8.32% |
| Revenue Per Employee | $342,195 |
| Profits Per Employee | $5,708 |
| Employee Count | 3,580 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 7.22 |
Taxes
In the past 12 months, Omnicell has paid $17.33 million in taxes.
| Income Tax | 17.33M |
| Effective Tax Rate | 45.89% |
Stock Price Statistics
The stock price has increased by +47.00% in the last 52 weeks. The beta is 0.86, so Omnicell's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | +47.00% |
| 50-Day Moving Average | 37.08 |
| 200-Day Moving Average | 36.60 |
| Relative Strength Index (RSI) | 77.21 |
| Average Volume (20 Days) | 502,247 |
Short Selling Information
The latest short interest is 2.52 million, so 5.54% of the outstanding shares have been sold short.
| Short Interest | 2.52M |
| Short Previous Month | 2.50M |
| Short % of Shares Out | 5.54% |
| Short % of Float | 6.01% |
| Short Ratio (days to cover) | 5.40 |
Income Statement
In the last 12 months, Omnicell had revenue of $1.23 billion and earned $20.43 million in profits. Earnings per share was $0.44.
| Revenue | 1.23B |
| Gross Profit | 537.47M |
| Operating Income | 40.14M |
| Pretax Income | 37.76M |
| Net Income | 20.43M |
| EBITDA | 72.61M |
| EBIT | 40.14M |
| Earnings Per Share (EPS) | $0.44 |
Full Income StatementBalance Sheet
The company has $239.22 million in cash and $190.56 million in debt, giving a net cash position of $48.66 million or $1.07 per share.
| Cash & Cash Equivalents | 239.22M |
| Total Debt | 190.56M |
| Net Cash | 48.66M |
| Net Cash Per Share | $1.07 |
| Equity (Book Value) | 1.26B |
| Book Value Per Share | 27.73 |
| Working Capital | 239.25M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $155.88 million and capital expenditures -$44.11 million, giving a free cash flow of $111.77 million.
| Operating Cash Flow | 155.88M |
| Capital Expenditures | -44.11M |
| Depreciation & Amortization | 32.47M |
| Net Borrowing | -175.00M |
| Free Cash Flow | 111.77M |
| FCF Per Share | $2.46 |
Full Cash Flow StatementMargins
Gross margin is 43.87%, with operating and profit margins of 3.28% and 1.67%.
| Gross Margin | 43.87% |
| Operating Margin | 3.28% |
| Pretax Margin | 3.08% |
| Profit Margin | 1.67% |
| EBITDA Margin | 5.93% |
| EBIT Margin | 3.28% |
| FCF Margin | 9.12% |